Kiessling M, Lindl T, Cramer H
Arch Psychiatr Nervenkr (1970). 1975 Dec 22;220(4):325-33. doi: 10.1007/BF00342062.
The effects of L-Dopa and the dopamine receptor stimulant ET-495 on cisternal cAMP levels were studied in rats. L-dopa (100-200 mg/kg) increased cisternal cAMP levels by 60 to 80% of controls. When peripheral Dopa-decarboxylase was inhibited, smaller doses of L-Dopa were effective. Fla-63, an inhibitor of dopamine-beta-hydroxylase lowered the increase induced by L-Dopa which was completely suppressed by propranolol, not by phentolamine, suggesting that the cAMP increase is mediated through a central beta-adrenoceptor stimulation. ET-495 failed to influence cAMP levels which argues against a dopamine-sensitive adenylate cyclase involved in the L-Dopa effect. Moreover, large increases of cisternal cAMP were observed after treatment with theophylline , not papaverine which suggests different effects of these "phosphodiesterase inhibitors" on the cyclic AMP systems in the central nervous system or on transport mechanisms.
在大鼠中研究了左旋多巴(L-Dopa)和多巴胺受体激动剂ET-495对脑池内cAMP水平的影响。左旋多巴(100 - 200mg/kg)使脑池内cAMP水平比对照组升高60%至80%。当外周多巴脱羧酶被抑制时,较小剂量的左旋多巴也有效。多巴胺-β-羟化酶抑制剂Fla-63降低了左旋多巴诱导的升高,普萘洛尔可完全抑制该升高,而酚妥拉明则不能,这表明cAMP的升高是通过中枢β-肾上腺素能受体刺激介导的。ET-495未能影响cAMP水平,这与参与左旋多巴作用的多巴胺敏感腺苷酸环化酶的观点相悖。此外,用茶碱而非罂粟碱处理后观察到脑池内cAMP大幅升高,这表明这些“磷酸二酯酶抑制剂”对中枢神经系统中环状AMP系统或转运机制有不同影响。